ID: MRFR/MED/5434-HCR | 85 Pages | Author: Rahul Gotadki | December 2023
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Blood Screening Market, by Technology
6.1 Introduction
6.2 Nucleic Acid Amplification Test (NAT)
6.2.1 Transcription-Mediated Amplification (TMA)
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.2 Real-Time Polymerase Chain Reaction (PCR)
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3 Enzyme-Linked Immunosorbent Assay (ELISA)
6.3.1 ELISA Market, By Platform
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.2 ELISA Market, By Generation
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.4 Rapid Tests
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.5 Next-Generation Sequencing (NGS)
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.6 Western Blotting
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 7. Global Blood Screening Market, by Product and Services
7.1 Introduction
7.2 Reagent and kits
7.2.1 NAT Reagents & Kits
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.2.2 ELISA Reagents & Kits
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3 Enzymes and Polymerases
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.4 Standards and Controls
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.5 Probes and Primers
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.6 Buffers, Nucleotides, and Solutions
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.7 Immunosorbents
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.8 Controls
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.9 Instruments
7.3.1 Rental Purchase
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3.2 Outright Purchase
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.4 Software and services
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 8. Global Blood Screening Market, By End User
8.1 Hospitals
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.2 Clinics
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3 Research Institutes and Academic Center
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.4 Blood Banks
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.5 Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 9. Global Blood Screening Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Grifols
11.1.1 Company Overview
11.1.2 Product and Services Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 F. Hoffmann-La Roche
11.2.1 Company Overview
11.2.2 Product and Services Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Product and Services Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Biomérieux
11.4.1 Company Overview
11.4.2 Product and Services Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Company Overview
11.5.2 Product and Services Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Siemens Healthineers (A Subsidiary of Siemens AG)
11.6.1 Company Overview
11.6.2 Product and Services Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Ortho Clinical Diagnostics, Inc.
11.7.1 Overview
11.7.2 Product and Services Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Overview
11.8.2 Product and Services Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Beckman Coulter (A Subsidiary of Danaher Corporation)
11.9.1 Overview
11.9.2 Product and Services Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Becton, Dickinson and Company
11.10.1 Overview
11.10.2 Product and Services Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Blood Screening Market Industry
Chapter 13. Appendix
LIST OF TABLES:
Table 1 Global Blood Screening Market Synopsis, 2023-2030
Table 2 Global Blood Screening Market Estimates and Forecast, 2023-2030 (USD Million)
Table 3 Global Blood Screening Market, by Region, 2023-2030 (USD Million)
Table 4 Global Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 5 Global Blood Screening, by Product and Services, 2023-2030 (USD Million)
Table 6 Global Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 7 North America: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 8 North America: Blood Screening, by Product and Services, 2023-2030 (USD Million)
Table 9 North America: Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 10 US: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 11 US: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 12 US: Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 13 Canada: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 14 Canada: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 15 Canada: Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 16 South America: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 17 South America: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 18 South America: Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 19 Europe: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 20 Europe: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 21 Europe: Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 22 Western Europe: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 23 Western Europe: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 24 Western Europe: Blood Screening Market, by End User, 2023-2030(USD Million)
Table 25 Eastern Europe: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 26 Eastern Europe: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 27 Eastern Europe: Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 28 Asia-Pacific: Blood Screening Market, by Technology, 2023-2030 (USD Million)
Table 29 Asia-Pacific: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 30 Asia-Pacific: Blood Screening Market, by End User, 2023-2030 (USD Million)
Table 31 Middle East & Africa: Blood Screening by Market, by Technology, 2023-2030 (USD Million)
Table 32 Middle East & Africa: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)
Table 33 Middle East & Africa Blood Screening Market, by End User, 2023-2030 (USD Million)
LIST OF FIGURES:
Figure 1 Research Process
Figure 2 Market Structure for Global Blood Screening Market
Figure 3 Market Dynamics for Global Blood Screening Market
Figure 4 Global Blood Screening Market Share, by Technology, 2023
Figure 5 Global Blood Screening Market Share, by Product and Services, 2023
Figure 6 Global Blood Screening Market Share, by End User, 2023
Figure 7 Global Blood Screening Market Share, by Region, 2023
Figure 8 North America: Blood Screening Market Share, by Country, 2023
Figure 9 Europe: Blood Screening Market Share, by Country, 2023
Figure 10 Asia-Pacific: Blood Screening Market Share, by Country, 2023
Figure 11 Middle East & Africa: Blood Screening Market Share, by Country, 2023
Figure 12 Global Blood Screening Market: Company Share Analysis, 2023 (%)
Figure 13 Grifols: Key Financials
Figure 14 Grifols: Segmental Revenue
Figure 15 Grifols: Geographical Revenue
Figure 16F. Hoffmann-La Roche: Key Financials
Figure 17F. Hoffmann-La Roche: Segmental Revenue
Figure 18F. Hoffmann-La Roche: Geographical Revenue
Figure 19Abbott Laboratories: Key Financials
Figure 20Abbott Laboratories: Segmental Revenue
Figure 21Abbott Laboratories: Geographical Revenue
Figure 22Biomérieux: Key Financials
Figure 23Biomérieux: Segmental Revenue
Figure 24Biomérieux: Geographical Revenue
Figure 25Bio-Rad Laboratories, Inc.: Key Financials
Figure 26Bio-Rad Laboratories, Inc.: Segmental Revenue
Figure 27Bio-Rad Laboratories, Inc.: Geographical Revenue
Figure 28Siemens Healthineers (A Subsidiary of Siemens AG): Key Financials
Figure 29Siemens Healthineers (A Subsidiary of Siemens AG): Segmental Revenue
Figure 30 Siemens Healthineers (A Subsidiary of Siemens AG): Geographical Revenue
Figure 31Ortho Clinical Diagnostics, Inc.: Key Financials
Figure 32Ortho Clinical Diagnostics, Inc.: Segmental Revenue
Figure 33Ortho Clinical Diagnostics, Inc.: Geographical Revenue
Figure 34Thermo Fisher Scientific, Inc.: Key Financials
Figure 35Thermo Fisher Scientific, Inc.: Segmental Revenue
Figure 36Thermo Fisher Scientific, Inc.: Geographical Revenue
Figure 37Beckman Coulter (A Subsidiary of Danaher Corporation): Key Financials
Figure 38 Beckman Coulter (A Subsidiary of Danaher Corporation): Segmental Revenue
Figure 39 Beckman Coulter (A Subsidiary of Danaher Corporation): Geographical Revenue
Figure 40Becton, Dickinson and Company: Key Financials
Figure 41Becton, Dickinson and Company: Segmental Revenue
Figure 42Becton, Dickinson and Company: Geographical Revenue
Blood Screening Market Segmentation
Blood Screening Technology Outlook (USD Billion, 2019-2030)
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Blood Screening End User Outlook (USD Billion, 2019-2030)
Hospitals
Clinics
Others
Blood Screening Product & Services Outlook (USD Billion, 2019-2030)
Reagents
Instrument
Blood Screening Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
North America Blood Screening by End User
Hospitals
Clinics
Others
North America Blood Screening by Product & Services
Reagents
Instrument
US Outlook (USD Billion, 2019-2030)
US Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
US Blood Screening by End User
Hospitals
Clinics
Others
US Blood Screening by Product & Services
Reagents
Instrument
CANADA Outlook (USD Billion, 2019-2030)
CANADA Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
CANADA Blood Screening by End User
Hospitals
Clinics
Others
CANADA Blood Screening by Product & Services
Reagents
Instrument
Europe Outlook (USD Billion, 2019-2030)
Europe Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Europe Blood Screening by End User
Hospitals
Clinics
Others
Europe Blood Screening by Product & Services
Reagents
Instrument
Germany Outlook (USD Billion, 2019-2030)
Germany Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Germany Blood Screening by End User
Hospitals
Clinics
Others
Germany Blood Screening by Product & Services
Reagents
Instrument
France Outlook (USD Billion, 2019-2030)
France Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
France Blood Screening by End User
Hospitals
Clinics
Others
France Blood Screening by Product & Services
Reagents
Instrument
UK Outlook (USD Billion, 2019-2030)
UK Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
UK Blood Screening by End User
Hospitals
Clinics
Others
UK Blood Screening by Product & Services
Reagents
Instrument
ITALY Outlook (USD Billion, 2019-2030)
ITALY Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
ITALY Blood Screening by End User
Hospitals
Clinics
Others
ITALY Blood Screening by Product & Services
Reagents
Instrument
SPAIN Outlook (USD Billion, 2019-2030)
Spain Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Spain Blood Screening by End User
Hospitals
Clinics
Others
Spain Blood Screening by Product & Services
Reagents
Instrument
Rest Of Europe Outlook (USD Billion, 2019-2030)
Rest Of Europe Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
REST OF EUROPE Blood Screening by End User
Hospitals
Clinics
Others
REST OF EUROPE Blood Screening by Product & Services
Reagents
Instrument
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Asia-Pacific Blood Screening by End User
Hospitals
Clinics
Others
Asia-Pacific Blood Screening by Product & Services
Reagents
Instrument
China Outlook (USD Billion, 2019-2030)
China Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
China Blood Screening by End User
Hospitals
Clinics
Others
China Blood Screening by Product & Services
Reagents
Instrument
Japan Outlook (USD Billion, 2019-2030)
Japan Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Japan Blood Screening by End User
Hospitals
Clinics
Others
Japan Blood Screening by Product & Services
Reagents
Instrument
India Outlook (USD Billion, 2019-2030)
India Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
India Blood Screening by End User
Hospitals
Clinics
Others
India Blood Screening by Product & Services
Reagents
Instrument
Australia Outlook (USD Billion, 2019-2030)
Australia Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Australia Blood Screening by End User
Hospitals
Clinics
Others
Australia Blood Screening by Product & Services
Reagents
Instrument
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Rest of Asia-Pacific Blood Screening by End User
Hospitals
Clinics
Others
Rest of Asia-Pacific Blood Screening by Product & Services
Reagents
Instrument
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Rest of the World Blood Screening by End User
Hospitals
Clinics
Others
Rest of the World Blood Screening by Product & Services
Reagents
Instrument
Middle East Outlook (USD Billion, 2019-2030)
Middle East Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Middle East Blood Screening by End User
Hospitals
Clinics
Others
Middle East Blood Screening by Product & Services
Reagents
Instrument
Africa Outlook (USD Billion, 2019-2030)
Africa Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Africa Blood Screening by End User
Hospitals
Clinics
Others
Africa Blood Screening by Product & Services
Reagents
Instrument
Latin America Outlook (USD Billion, 2019-2030)
Latin America Blood Screening by Technology
Nucleic Acid Amplification Test
Enzyme-Linked Immunosorbent Assay
Next-Generation Sequencing
Latin America Blood Screening by End User
Hospitals
Clinics
Others
Latin America Blood Screening by Product & Services
Reagents
Instrument
Â